Literature DB >> 23958398

How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.

Syed A Morshed1, Risheng Ma, Rauf Latif, Terry F Davies.   

Abstract

Thyroid stimulating hormone (TSH) activates two major G-protein arms, Gsα and Gq leading to initiation of down-stream signaling cascades for survival, proliferation and production of thyroid hormones. Antibodies to the TSH receptor (TSHR-Abs), found in patients with Graves' disease, may have stimulating, blocking, or neutral actions on the thyroid cell. We have shown previously that such TSHR-Abs are distinct signaling imprints after binding to the TSHR and that such events can have variable functional consequences for the cell. In particular, there is a great contrast between stimulating (S) TSHR-Abs, which induce thyroid hormone synthesis and secretion as well as thyroid cell proliferation, compared to so called "neutral" (N) TSHR-Abs which may induce thyroid cell apoptosis via reactive oxygen species (ROS) generation. In the present study, using a rat thyrocyte (FRTL-5) ex vivo model system, our hypothesis was that while N-TSHR-Abs can induce apoptosis via activation of mitochondrial ROS (mROS), the S-TSHR-Abs are able to stimulate cell survival and avoid apoptosis by actively suppressing mROS. Using fluorescent microscopy, fluorometry, live cell imaging, immunohistochemistry and immunoblot assays, we have observed that S-TSHR-Abs do indeed suppress mROS and cellular stress and this suppression is exerted via activation of the PKA/CREB and AKT/mTOR/S6K signaling cascades. Activation of these signaling cascades, with the suppression of mROS, initiated cell proliferation. In sharp contrast, a failure to activate these signaling cascades with increased activation of mROS induced by N-TSHR-Abs resulted in thyroid cell apoptosis. Our current findings indicated that signaling diversity induced by different TSHR-Abs regulated thyroid cell fate. While S-TSHR-Abs may rescue cells from apoptosis and induce thyrocyte proliferation, N-TSHR-Abs aggravate the local inflammatory infiltrate within the thyroid gland, or in the retro-orbit, by inducing cellular apoptosis; a phenomenon known to activate innate and by-stander immune-reactivity via DNA release from the apoptotic cells. Published by Elsevier Ltd.

Entities:  

Keywords:  Antibodies; Apoptosis; Proliferation; ROS-signaling; TSH receptor; Thyrocyte

Mesh:

Substances:

Year:  2013        PMID: 23958398      PMCID: PMC3872079          DOI: 10.1016/j.jaut.2013.07.009

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  34 in total

1.  Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism.

Authors:  L Iacovelli; L Capobianco; L Salvatore; M Sallese; G M D'Ancona; A De Blasi
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 2.  cAMP-PKA signaling to the mitochondria: protein scaffolds, mRNA and phosphatases.

Authors:  Antonio Feliciello; Max E Gottesman; Enrico V Avvedimento
Journal:  Cell Signal       Date:  2005-03       Impact factor: 4.315

Review 3.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

4.  Activating transcription factor 1 and CREB are important for cell survival during early mouse development.

Authors:  Susanne C Bleckmann; Julie A Blendy; Dorothea Rudolph; A Paula Monaghan; Wolfgang Schmid; Günther Schütz
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Heterogeneous responses of recombinant human thyrotropin receptor to immunoglobulins from patients with Graves' disease.

Authors:  T Endo; M Ohmori; M Ikeda; E Anzai; T Onaya
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

6.  Graves' IgG recognizes linear epitopes in the human thyrotropin receptor.

Authors:  E V Nagy; H B Burch; K Mahoney; Y G Lukes; J C Morris; K D Burman
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

7.  Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy.

Authors:  Onur Konuk; Ahmet Hondur; Nalan Akyurek; Mehmet Unal
Journal:  Ocul Immunol Inflamm       Date:  2007 Mar-Apr       Impact factor: 3.070

8.  Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.

Authors:  Heng Du; Lan Guo; Xiaoping Wu; Alexander A Sosunov; Guy M McKhann; John Xi Chen; Shirley ShiDu Yan
Journal:  Biochim Biophys Acta       Date:  2013-03-16

9.  cAMP/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation.

Authors:  Jane E Leadsham; Campbell W Gourlay
Journal:  BMC Cell Biol       Date:  2010-11-25       Impact factor: 4.241

10.  Mitochondria-ros crosstalk in the control of cell death and aging.

Authors:  Saverio Marchi; Carlotta Giorgi; Jan M Suski; Chiara Agnoletto; Angela Bononi; Massimo Bonora; Elena De Marchi; Sonia Missiroli; Simone Patergnani; Federica Poletti; Alessandro Rimessi; Jerzy Duszynski; Mariusz R Wieckowski; Paolo Pinton
Journal:  J Signal Transduct       Date:  2011-11-14
View more
  20 in total

1.  Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Sci Signal       Date:  2018-01-23       Impact factor: 8.192

2.  Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival In Vivo.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2019-06-04       Impact factor: 6.568

3.  New small molecule agonists to the thyrotropin receptor.

Authors:  Rauf Latif; M Rejwan Ali; Risheng Ma; Martine David; Syed A Morshed; Michael Ohlmeyer; Dan P Felsenfeld; Zerlina Lau; Mihaly Mezei; Terry F Davies
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

4.  A Modifying Autoantigen in Graves' Disease.

Authors:  Rauf Latif; Mihaly Mezei; Syed A Morshed; Risheng Ma; Rachel Ehrlich; Terry F Davies
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

5.  Rescue of thyroid cells from antibody induced cell death via induction of autophagy.

Authors:  Syed Morshed; Rauf Latif; Terry F Davies
Journal:  J Autoimmun       Date:  2021-11-18       Impact factor: 7.094

Review 6.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 7.  Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.

Authors:  S A Morshed; T F Davies
Journal:  Horm Metab Res       Date:  2015-09-11       Impact factor: 2.936

Review 8.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

9.  mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease.

Authors:  Xiaoming Yin; Ravi Sachidanandam; Syed Morshed; Rauf Latif; Ruijin Shi; Terry F Davies
Journal:  J Clin Endocrinol Metab       Date:  2014-06-27       Impact factor: 5.958

10.  Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy.

Authors:  G J Kahaly; S Ignjatović; M Sarić Matutinović; T Diana; B Nedeljković Beleslin; J Ćirić; M Žarković
Journal:  J Endocrinol Invest       Date:  2021-07-29       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.